Found: 20
Select item for more details and to access through your institution.
Acetylsalicylic Acid with Ascorbate: A Promising Combination Therapy for Solid Tumors.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 303, doi. 10.1007/s40268-024-00479-1
- By:
- Publication type:
- Article
Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 239, doi. 10.1007/s40268-024-00469-3
- By:
- Publication type:
- Article
Normalization of Hemoglobin, Lactate Dehydrogenase, and Fatigue in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Pegcetacoplan.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 169, doi. 10.1007/s40268-024-00463-9
- By:
- Publication type:
- Article
Pharmacokinetics and Bioequivalence of Two Formulations of Azithromycin Tablets: A Randomized, Single-Dose, Three-Period, Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed Conditions.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 201, doi. 10.1007/s40268-024-00464-8
- By:
- Publication type:
- Article
Pharmacokinetic Bioequivalence and Safety Assessment of Two Venlafaxine Hydrochloride Extended-Release Capsules in Healthy Chinese Subjects Under Fed Conditions: A Randomized, Open-Label, Single-Dose, Crossover Study.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 275, doi. 10.1007/s40268-024-00470-w
- By:
- Publication type:
- Article
The Importance of Patient Reported Outcomes in Oncology Clinical Trials and Clinical Practice to Inform Regulatory and Healthcare Decision-Making.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 123, doi. 10.1007/s40268-024-00478-2
- By:
- Publication type:
- Article
Pharmacokinetics, Tolerability, and Safety of Esmethadone in Subjects with Chronic Kidney Disease or Hepatic Impairment.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 341, doi. 10.1007/s40268-024-00477-3
- By:
- Publication type:
- Article
Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d'Ivoire.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 331, doi. 10.1007/s40268-024-00476-4
- By:
- Publication type:
- Article
Exploring the Relationship Between Atorvastatin and Memory Loss: A Comprehensive Analysis Integrating Real-World Pharmacovigilance and Mendelian Randomization.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 317, doi. 10.1007/s40268-024-00474-6
- By:
- Publication type:
- Article
Antibody–Drug Conjugates in the Pipeline for Treatment of Melanoma: Target and Pharmacokinetic Considerations.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 129, doi. 10.1007/s40268-024-00473-7
- By:
- Publication type:
- Article
Safety and Efficacy of Lemborexant in Insomnia Patients: Results of a Postmarketing Observational Study of Dayvigo<sup>®</sup> Tablets.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 211, doi. 10.1007/s40268-024-00462-w
- By:
- Publication type:
- Article
Demonstration of Physicochemical and Functional Similarity of Biosimilar Pegfilgrastim-cbqv to Pegfilgrastim.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 285, doi. 10.1007/s40268-024-00471-9
- By:
- Publication type:
- Article
A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 253, doi. 10.1007/s40268-024-00467-5
- By:
- Publication type:
- Article
Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 227, doi. 10.1007/s40268-024-00465-7
- By:
- Publication type:
- Article
Comparative CNS Pharmacology of the Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib Versus Other BTK Inhibitor Candidates for Treating Multiple Sclerosis.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 263, doi. 10.1007/s40268-024-00468-4
- By:
- Publication type:
- Article
A Semi-Mechanistic Population Pharmacokinetic Model of Noscapine in Healthy Subjects Considering Hepatic First-Pass Extraction and CYP2C9 Genotypes.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 187, doi. 10.1007/s40268-024-00466-6
- By:
- Publication type:
- Article
PD-1 Inhibitor Induced Hypertrophic Lichen Planus: A Case Report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 179, doi. 10.1007/s40268-024-00460-y
- By:
- Publication type:
- Article
Retrospective Assessment of Translational Pharmacokinetic–Pharmacodynamic Modeling Performance: A Case Study with Apitolisib, a Dual PI3K/mTOR Inhibitor.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 155, doi. 10.1007/s40268-024-00459-5
- By:
- Publication type:
- Article
Evaluation of Ornidazole Tablets Bioequivalence in Chinese Healthy Participants Under Fasted and Fed Conditions Using Pharmacokinetic Parameters.
- Published in:
- Drugs in R&D, 2024, v. 24, n. 2, p. 145, doi. 10.1007/s40268-024-00457-7
- By:
- Publication type:
- Article